NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Beth Smith ME, Nelson HD, Haney E, et al. Diagnosis and Treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Rockville (MD): Agency for Healthcare Research and Quality (US); 2014 Dec. (Evidence Reports/Technology Assessments, No. 219.)
This publication is provided for historical reference only and the information may be out of date.
The Agency for Healthcare Research and Quality (AHRQ), through its Evidence-based Practice Centers (EPCs), sponsors the development of evidence reports and technology assessments to assist public- and private-sector organizations in their efforts to improve the quality of health care in the United States. The National Institutes of Health requested and provided funding for this report to inform their Pathways to Prevention Workshop.
The reports and assessments provide comprehensive, evidence-based information on common, medical conditions and new health care technologies and strategies. They also identify research gaps in the selected scientific area, identify methodological and scientific weaknesses, suggest research needs, and move the field forward through an unbiased, evidence-based assessment of the available literature. The EPCs systematically review the relevant scientific literature on topics assigned to them by AHRQ and conduct additional analyses when appropriate prior to developing their reports and assessments.
To bring the broadest range of experts into the development of evidence reports and health technology assessments, AHRQ encourages the EPCs to form partnerships and enter into collaborations with other medical and research organizations. The EPCs work with these partner organizations to ensure that the evidence reports and technology assessments they produce will become building blocks for health care quality improvement projects throughout the Nation. The reports undergo peer review and public comment prior to their release as a final report.
AHRQ expects that the EPC evidence reports and technology assessments, when appropriate, will inform individual health plans, providers, and purchasers as well as the health care system as a whole by providing important information to help improve health care quality.
We welcome comments on this evidence report. They may be sent by mail to the Task Order Officer named below at: Agency for Healthcare Research and Quality, 540 Gaither Road, Rockville, MD 20850, or by email to vog.shh.qrha@cpe.
- Richard G. Kronick, Ph.D.DirectorAgency for Healthcare Research and Quality
- Stephanie Chang, M.D., M.P.H.DirectorEPC ProgramCenter for Evidence and Practice ImprovementAgency for Healthcare Research and Quality
- David Meyers, M.D.Acting DirectorCenter for Evidence and Practice ImprovementAgency for Healthcare Research and Quality
- Suchitra Iyer, Ph.D.Task Order OfficerCenter for Evidence and Practice ImprovementAgency for Healthcare Research and Quality
- Preface - Diagnosis and Treatment of Myalgic Encephalomyelitis/Chronic Fatigue S...Preface - Diagnosis and Treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
- MHC class II antigen [Homo sapiens]MHC class II antigen [Homo sapiens]gi|1686075569|gb|QDC22499.1|Protein
- 602305576F1 NIH_MGC_88 Homo sapiens cDNA clone IMAGE:4396867 5', mRNA sequence602305576F1 NIH_MGC_88 Homo sapiens cDNA clone IMAGE:4396867 5', mRNA sequencegi|12386128|gnl|dbEST|7540724|gb|BF 6.1|Nucleotide
Your browsing activity is empty.
Activity recording is turned off.
See more...